Literature DB >> 7059998

Factors that influence initiation and growth of 9L rat brain gliosarcoma multicellular spheroids.

Y Sano, D F Deen, T Hoshino.   

Abstract

This report details optimum conditions for initiating and growing 9L rat brain gliosarcoma multicellular spheroids. Best results were achieved when 0.5 to 2.0 x 10(6) cells were seeded initially into agarose (0.5 to 1.0%)-coated Petri dishes. Spheroids initiated in this manner appeared to grow in spinner culture at a rate slightly faster than spheroids initiated and grown in spinner culture. An optimum growth rate was obtained for individual spheroids grown in the well of cluster dishes coated with 0.5 to 0.75% agarose in growth medium containing 10% newborn calf serum and 0.9 g glucose per liter. Three methods for dissociation of spheroids at both room temperature and 37 degrees have been developed. The "race track" method of fractional dissociation produced a constant and similar number of cells for each disaggregation interval, and the plating efficiency of cells in each fraction was similar.

Entities:  

Mesh:

Year:  1982        PMID: 7059998

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Development of subrenal capsule tumours following transplantation of rat RN6 multicell spheroids.

Authors:  S Krajewski; W Wechsler
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

2.  Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture.

Authors:  L Fjellbirkeland; R Bjerkvig; O D Laerum
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 3.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 4.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

Authors:  R D Fross; P C Warnke; D R Groothuis
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.